Although the importance of the cGAS–STING pathway in dictating anti-tumor immunity through potentiating type I IFN production was recently shown, this study may provide additional insight into CX-5461-mediated anti-tumor activity through the cGAS–STING pathway which can be implicated in cancer therapy. The gene discussed is STING1; the disease is cancer.